With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...

After Teddi Mellencamp shared her cancer had progressed earlier this year, she shared why she has felt “sicker” amid ...

In a significant advancement for prostate cancer research, a first-of-its kind study led by Emory researchers uncovered how the disease transforms ...

I must begin this story by emphasising the importance of periodic medical examinations to ensure that any illness is detected ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

During Monday's episode of On Air with Ryan Seacrest, Ryan Seacrest opened up about his father, Gary Seacrest's, battle with ...

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

Ryan Seacrest is getting candid. Seacrest, 50, got emotional and teared up during a July 21 broadcast of “On Air With Ryan ...

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...